What’s Next for CAREVIEW COMMUNICATIONS INC (OTCMKTS:CRVW) After Having Less Shares Shorted?

CareView Communications, Inc. (OTCMKTS:CRVW) Logo

The stock of CAREVIEW COMMUNICATIONS INC (OTCMKTS:CRVW) registered a decrease of 22.77% in short interest. CRVW’s total short interest was 300,500 shares in December as published by FINRA. Its down 22.77% from 389,100 shares, reported previously. With 64,900 shares average volume, it will take short sellers 5 days to cover their CRVW’s short positions.

It closed at $0.0275 lastly. It is down 0.00% since December 7, 2017 and is . It has underperformed by 15.62% the S&P500.

CareView Communications, Inc. provides products and on-demand application services for the healthcare industry in the United States. The company has market cap of $3.83 million. The firm offers SecureView module to monitor and record bedside activity in the patient's room; NurseView module to view monitored rooms from the nurse's station; PhysicianView module to view patients from any personal computer; Virtual Bed Rails and Virtual Chair Rails fall prevention modules; Fall Management Program to separately file, identify, and research the activity of patients; and timed rounding modules to help nursing staff monitor patients. It currently has negative earnings. It also provides Sitter Management Program to monitor patient rooms from nursing station or mobile device; BedView module to monitor the status and availability of facility beds remotely; delivery mechanism for patient education materials; FacilityView module that monitors and records activity in any area that the hospital would desire security cameras to be placed; monitoring system for nursing alerts and reminders; and ulcer management systems.

Another recent and important CareView Communications, Inc. (OTCMKTS:CRVW) news was published by Seekingalpha.com which published an article titled: “Careview Communications Is A Terminal Short – Seeking Alpha” on August 21, 2012.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.